Company may now initiate Phase 2b trial for treatment of demoralization syndrome in patients with cancerNEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental health conditions related to life-altering diseases, today announces that the Company has received a Safe to Proceed notification from the U.S. Food and Drug Administration (FDA) regarding its Invest
EQS-News: Reset Pharmaceuticals, Inc.: Reset Pharma Receives Notice of Safe to Proceed from FDA for Investigational New Drug (IND) Application for Oral Psilocybin RSTP1000 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
EQS-News: Reset Pharmaceuticals, Inc. / Key word(s): Personnel Reset Pharmaceuticals Appoints Innes Meldrum as President and Chief Executive Officer 05.01.2023 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Reset Pharmaceuticals Appoints Innes Meldrum as.
EQS-News: Reset Pharmaceuticals, Inc. / Key word(s): Personnel Reset Pharmaceuticals announces appointment of neuroscience industry leader Lisa Deschamps to the Board of Directors 02.11.2022 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. Reset Pharmaceut.